Literature DB >> 23801053

Assessing the effectiveness of a Grand Rounds CME activity for health-care professionals.

Terry Ann Glauser1, P Holder Nevins, J Chad Williamson, Brian Tomlinson.   

Abstract

The Lymphoma Research Foundation offers Grand Rounds continuing medical education (CME) activities on specific issues related to advances in the management of patients with lymphoma. The 2012 activity comprised interactive case studies presented by local lymphoma experts. A case-based survey was designed to assess whether the management choices of program participants are consistent with the evidence-based content of the CME activity. This survey was administered to participants 1 month after completion of the CME activity and also to a control group who did not participate in the educational program. Participants were more aware of the epidemiology of CD20-positive tumors than were controls and were more likely to appropriately diagnose primary mediastinal large B cell lymphoma (PMBCL), use evidence-based second-line therapy for PMBCL, and properly manage a patient with classic Hodgkin lymphoma that did not respond to standard therapy. Participants were also more confident than controls in their ability to interpret histology and cytogenetic testing for selecting an optimal treatment.

Entities:  

Mesh:

Year:  2013        PMID: 23801053     DOI: 10.1007/s13187-013-0507-8

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  24 in total

1.  Using the Internet to conduct surveys of health professionals: a valid alternative?

Authors:  Dejana Braithwaite; Jon Emery; Simon De Lusignan; Stephen Sutton
Journal:  Fam Pract       Date:  2003-10       Impact factor: 2.267

Review 2.  The molecular pathogenesis of primary mediastinal large B-cell lymphoma.

Authors:  Christian Steidl; Randy D Gascoyne
Journal:  Blood       Date:  2011-06-23       Impact factor: 22.113

3.  B cells and macrophages in cancer: yin and yang.

Authors:  Alberto Mantovani
Journal:  Nat Med       Date:  2011-03       Impact factor: 53.440

4.  Revised response criteria for malignant lymphoma.

Authors:  Bruce D Cheson; Beate Pfistner; Malik E Juweid; Randy D Gascoyne; Lena Specht; Sandra J Horning; Bertrand Coiffier; Richard I Fisher; Anton Hagenbeek; Emanuele Zucca; Steven T Rosen; Sigrid Stroobants; T Andrew Lister; Richard T Hoppe; Martin Dreyling; Kensei Tobinai; Julie M Vose; Joseph M Connors; Massimo Federico; Volker Diehl
Journal:  J Clin Oncol       Date:  2007-01-22       Impact factor: 44.544

5.  Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality.

Authors:  J W Peabody; J Luck; P Glassman; T R Dresselhaus; M Lee
Journal:  JAMA       Date:  2000-04-05       Impact factor: 56.272

6.  Multimodal CME for surgeons and pathologists improves colon cancer staging.

Authors:  Andrew J Smith; Calvin H L Law; Mahmoud A Khalifa; Eugene T K Hsieh; Sherif S Hanna; Frances C Wright; Peeter A Poldre
Journal:  J Cancer Educ       Date:  2003       Impact factor: 2.037

7.  Beyond doughnuts: tumor board recommendations influence patient care.

Authors:  John K Petty; John T Vetto
Journal:  J Cancer Educ       Date:  2002       Impact factor: 2.037

8.  Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.

Authors:  Volker Diehl; Jeremy Franklin; Michael Pfreundschuh; Bernd Lathan; Ursula Paulus; Dirk Hasenclever; Hans Tesch; Richard Herrmann; Bernd Dörken; Hans-Konrad Müller-Hermelink; Eckhardt Dühmke; Markus Loeffler
Journal:  N Engl J Med       Date:  2003-06-12       Impact factor: 91.245

9.  Infusional cyclophosphamide, doxorubicin, and etoposide in relapsed and resistant non-Hodgkin's lymphoma: evidence for a schedule-dependent effect favoring infusional administration of chemotherapy.

Authors:  J A Sparano; P H Wiernik; A Leaf; J P Dutcher
Journal:  J Clin Oncol       Date:  1993-06       Impact factor: 44.544

10.  Measuring the quality of physician practice by using clinical vignettes: a prospective validation study.

Authors:  John W Peabody; Jeff Luck; Peter Glassman; Sharad Jain; Joyce Hansen; Maureen Spell; Martin Lee
Journal:  Ann Intern Med       Date:  2004-11-16       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.